Acumen Pharmaceuticals (ABOS) Stock Price Target 2026

The average analyst price target for Acumen Pharmaceuticals is $5.71, 2593.4% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $1 to $11. The latest change came on Nov 2, 2026, when BTIG lowered its price target on Acumen Pharmaceuticals from $8 to $1 and kept a Buy rating.

The Average Analyst Price Target for Acumen Pharmaceuticals is $5.71.

Price Target Range — 12 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$5.71Upside to Avg. PT+2593.4%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Acumen Pharmaceuticals Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 2, 2026	BTIG	Thomas Shrader	PT Cut	Buy	$8→$1
Oct 30, 2026	Citigroup	Geoff Meacham	Downgrade	Buy→Neutral	$5→$1
Sep 16, 2026	BTIG	Thomas Shrader	Maintained	Buy	$8
Sep 15, 2026	Citigroup	Geoff Meacham	PT Raise	Buy	$4→$5
Mar 26, 2026	BTIG	Thomas Shrader	Maintained	Buy	$8
Mar 16, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$7→$8
Jan 27, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$4→$7
Nov 18, 2025	B of A Securities	Geoff Meacham	PT Cut	Buy	$9→$8
Aug 25, 2025	B of A Securities	Geoff Meacham	PT Cut	Buy	$10→$9
Jun 17, 2025	Citigroup	Geoff Meacham	Initiate	Buy	$4
Mar 28, 2025	UBS	Colin Bristow	PT Cut	Buy	$6→$4
Mar 28, 2025	HC Wainwright & Co.	Andrew Fein	PT Cut	Buy	$15→$11
Nov 13, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Oct 3, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Aug 15, 2024	UBS	Colin Bristow	PT Cut	Buy	$14→$6
Aug 14, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Jul 25, 2024	Citigroup	David Hoang	Initiate	Buy	$7
May 15, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15
Mar 31, 2024	UBS	Colin Bristow	PT Cut	Buy	$15→$14
Mar 27, 2024	HC Wainwright & Co.	Andrew Fein	Maintained	Buy	$15